NCT04485013 2026-02-18
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Tizona Therapeutics, Inc
Phase 1 Recruiting
Tizona Therapeutics, Inc
AbbVie
Medical College of Wisconsin
AbbVie
Amgen
AbbVie
CR-CSSS Champlain-Charles-Le Moyne
Amgen
Amgen